Tabotta, Flavian http://orcid.org/0000-0002-6267-0590
Ferretti, Gilbert R.
Prosch, Helmut
Boussouar, Samia
Brun, Anne-Laure
Roos, Justus E.
Ebner, Lukas
Letovanec, Igor
Brauner, Michel
Beigelman-Aubry, Catherine
Article History
Received: 2 June 2020
Accepted: 3 September 2020
First Online: 15 October 2020
Ethics approval and consent to participate
: Need for ethic committee approval was waived.Consent to participate is not applicable.
: Figures of this paper are entirely anonymized, i.e., individuals cannot be identified, and no formal consent was provided.
: Dr. Beigelman-Aubry reports personal fees from Astra Zeneca, personal fees from Gilead, and personal fees from Boehringer Ingelheim, outside the submitted work.Dr. Ferretti reports personal fees from Roche SAS, personal fees from Boehringer, personal fees from General Electric medical care, personal fees from BMS, non-financial support from Guerbet, personal fees from Astra Zeneca, and personal fees from MSD, outside the submitted work.Other authors have nothing to disclose.